Submitted by LuAnne Ronning on
Please join us for...
• The Experts • The Panels • The Controversies
• The Exhibits • The Networking • The Socializing
• The 25th Anniversary GALA
When you attend the "Annual National Conference" you will have two-and-a-half days to gain accredited insight from some of the nation’s foremost clinical experts in the areas of:
25th ANC Registration fee:
Need CE credits?
Register Today! Don’t miss participating in this milestone event!
> REGISTRATION IS CLOSED!
Who should attend?
The “25th Annual National Conference” is designed for health care professionals who are interested in learning best practices for optimal patient/benefit management in the areas of: organ and blood/marrow transplantation; health and wellness; comorbid diseases; complex-medical-condition support; case management; and utilization management, such as:
Here's what last year's attendees have to say about their experience:
** Refer to the Continuing Education page for a listing of certifications that have been applied for and/or approved for this conference.
The instructional level of the educational activity is intermediate.
Conference educational objectives
After completion of this activity, the participant should be able to:
- Explore advances in medical and surgical management of diabetes, including DPP-4 and SGLT2 inhibitors, SGLT1 receptor agonists, pancreas and islet transplant, and the utility of stem-cell-derived beta cells for future treatment of diabetes.
- Recognize advanced treatment approaches for HIV and hepatitis C and acknowledge how these infectious diseases continue to represent a significant public health risk.
- Identify transplant-recipient- and caregiver-reported challenges with regard to hematopoietic stem cell transplant and coordination of care for this population.
- Discuss current research and best-practice standards for optimal management of heart failure, and debate the pros and cons of heart transplant versus ventricular assist device for patients over 70 years of age.
- Describe the various types of cancer immunotherapy to include monoclonal antibodies, cancer vaccines, chimeric-antigen receptor (CAR) T-cell therapy, and immune-checkpoint inhibitors, and outline their clinical applications.
- Explain the various approaches to matching and allocation in kidney paired donation and strategies for transplantation across blood barriers in ABO-incompatible kidney transplantation.
- State current and new therapeutic approaches for the treatment of multiple myeloma.
- Discuss value-based care and payment models inherent to transplantation; the impact of Centers for Medicare & Medicaid Services regulations regarding outcomes on donor and recipient selection; and explain how the Affordable Care Act has changed the landscape of transplantation.
- Address some of the ethical and/or controversial topics surrounding transplantation.
- Analyze the disparities in transplantation through redistricting.